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Autophagy is a homeostatic process involved in the
bulk degradation of cytoplasmic components,
including damaged organelles and proteins. In both
genetic and dietary models of obesity, we observed
a severe downregulation of autophagy, particularly
in Atg7 expression levels in liver. Suppression of
Atg7 both in vitro and in vivo resulted in defective
insulin signaling and elevated ER stress. In contrast,
restoration of the Atg7 expression in liver resulted in
dampened ER stress, enhanced hepatic insulin
action, and systemic glucose tolerance in obese
mice. The beneficial action of Atg7 restoration in
obese mice could be completely prevented by block-
ing a downstream mediator, Atg5, supporting its
dependence on autophagy in regulating insulin
action. Our data demonstrate that autophagy is an
important regulator of organelle function and insulin
signaling and that loss of autophagy is a critical
component of defective insulin action seen in
obesity.
INTRODUCTION
Autophagy is a highly regulated process involved in the turnover
of long-lived proteins, cytosolic components, or damaged
organelles (Yorimitsu and Klionsky, 2005). As a putative adaptive
catabolic process, autophagy could generate energy for cells
under nutrient-poor conditions or during starvation and could
help to maintain cellular homeostasis in nutrient-rich environ-
ments through its constitutive activity (Lum et al., 2005;
Yorimitsu and Klionsky, 2005). In fact, impairment of this process
has been implicated in a number of human diseases (Levine and
Kroemer, 2008).
Obesity represents a condition wherein the proper sensing
and management of nutrients and energy status present
significant challenges at the cellular and organismic levels.
The organism cannot adapt and maintain homeostasis under
continuous energy and nutrient exposure, and the consequent
emergence of metabolic and oxidative stress leads to inflam-
mation responses and organelle dysfunction (Hotamisligil,
2006, 2010). Chronic exposure to high energy and nutrient
intake increases the demand on the cellular synthetic andCdegradation machinery in tissues such as liver, adipose
tissue, and pancreas, all of which are central to systemic
metabolic homeostasis. Several observations led us to
explore a link between obesity and alterations in autophagy.
First, obesity is a condition of continuous and excess energy
and nutrient flow into the system that would challenge this
adaptive response. Second, ineffective macromolecule turn-
over, such as lipids or glycogen, could compromise hepatic
metabolic function and promote defective insulin action.
Third, there are suggested links between autophagy and
immune response (Levine and Deretic, 2007), which exhibit
abnormalities in obesity. Fourth, autophagy might be benefi-
cial for cells to dispose of damaged cell structures caused
by these stresses, and defective autophagy may lead to the
failure of restoration of cellular homeostasis, including organ-
elle function, thus exacerbating insulin resistance and possibly
other metabolic pathologies associated with obesity. This may
be particularly relevant to the endoplasmic reticulum (ER)
function because obesity is characterized by ER stress (Gre-
gor and Hotamisligil, 2007; Ozcan et al., 2004). It has been
suggested that ER may be a source of the membranes during
the formation of autophagic vesicles (Axe et al., 2008; Razi
et al., 2009) and that experimental ER stress can induce au-
tophagy in mammalian cells (Ogata et al., 2006), with several
canonical UPR (unfolded protein response) pathways impli-
cated in this interaction (Kouroku et al., 2007; Ogata et al.,
2006). It has also been postulated that ER stress-induced au-
tophagy may have evolved as a mechanism to dispose mis-
folded proteins that cannot be degraded by ER-associated
proteosomal degradation (ERAD) and, consequently, assist
ER homeostasis (Ding and Yin, 2008). Of interest, two recent
studies (Ebato et al., 2008; Jung et al., 2008) independently
demonstrated the importance of autophagy in the preserva-
tion of pancreatic b cell function. Because b cell function is
also influenced by ER stress and defective insulin secretion
is critical in obesity-induced insulin resistance and diabetes
(Lipson et al., 2006; Scheuner and Kaufman, 2008), these
findings also support a role for autophagy in metabolic
homeostasis. Finally, autophagy is regulated by the integrated
actions of insulin and mTOR (Ellington et al., 2006; Mammu-
cari et al., 2007; Xie and Klionsky, 2007), both of which are
altered in obesity. Hence, dysregulation of autophagy could
be a critical component of obesity and could contribute to
metabolic dysfunction triggered by this condition, including
the emergence of ER stress responses. In this study, we
set out to examine the autophagic response in obesity and
whether this process is involved in the emergence of insulinell Metabolism 11, 467–478, June 9, 2010 ª2010 Elsevier Inc. 467
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energy balance.
RESULTS
Downregulation of Hepatic Autophagy in Obesity
To study the regulation of autophagy in obesity, we first exam-
ined the expression patterns of several molecular indicators of
autophagy in both genetic (ob/ob) and dietary (high-fat diet-
induced [HFD]) models of murine obesity. Surprisingly, we found
that obesity resulted in markedly decreased autophagy indica-
tors in liver of both genetic and dietary models, as evidenced
by downregulation of LC3, Beclin 1 (also called Atg6), Atg5,
and, in particular, Atg7 protein levels (Figure 1A and
Figure S1A available online). In contrast, p62 (also called
SQSTM1, which is involved in aggresome formation and
degraded through autophagy) (Bjørkøy et al., 2005) is elevated
in the liver tissue of ob/ob mice compared to lean controls
(Figure 1A). The liver of ob/ob mice also exhibited elevated ER
stress, as evident by an induction of phosphorylated PERK
(PKR-like endoplasmic reticulum kinase) and IRE1 (inositol
requiring 1) proteins. Electron microscopic examination of the
liver tissue demonstrated significant reduction in autophago-
some/autolysosome formation in obese mice, supporting the
biochemical alterations in key autophagy molecules (Figures
1B and 1C). We also examined whether the ob/ob mice are
responsive to food withdrawal by induction of autophagy in the
liver. As shown in Figure 1D, food withdrawal failed to activate
autophagy in the liver tissue of obese animals, further supporting
the abnormal nature of autophagic response in obesity. Consid-
ering the possibility that the low levels of autophagy markers
such as LC3-II seen in obese liver tissuemay reflect a more rapid
turnover rather than deficiency, we treated the ob/ob mice ex-
pressing GFP-LC3 in the liver with chloroquine, a lysosomal
protease inhibitor, and then monitored the formation of autopha-
gosome. After an overnight fast, very few GFP-LC3-positive
punctate structures typical of enhanced autophagy were detect-
able in the liver tissue of the ob/obmice compared to the strong
signals observed in lean controls (Figures 1E and 1F). In addition
to significantly higher amounts of punctate structures decorated
with GFP-LC3, there was also enhanced distribution of LC3 in
the lean liver tissue following lysosomal enzyme inhibition
(Figures 1E and 1F). Taken together, these observations
confirmed that defective biochemical markers in obese liver
are not reflecting rapid autophagic efflux but are indicative of
defects in the activity of this pathway.
Regulation of Atg7 in Obesity
We next explored potential mechanisms that may underlie the
defective Atg7 expression and/or autophagy in obese liver
tissue. First, we examined the time course of the changes in
Atg7 expression in mouse liver during the development of
HFD obesity. As shown in Figure S1B, the decreased hepatic
Atg7 expression was evident at 16 weeks and was essentially
completely abolished at 22 weeks of HFD feeding. As hyperin-
sulinemia occurs with insulin resistance and autophagy is nega-
tively regulated by the activity of insulin-mTOR axis, we
explored whether deficiency of autophagy in obesity is the
result of hyperinsulinemia. For this, we administered streptozo-468 Cell Metabolism 11, 467–478, June 9, 2010 ª2010 Elsevier Inc.tocin (STZ) into the ob/ob mice, which leads to destruction of
b cells and insulinopenia, followed by examination of Atg7
expression. As shown in Figure S2A, STZ treatment results in
a 5-fold decrease in serum insulin levels in ob/ob mice.
However, this decline in insulin level did not restore the Atg7
expression level in liver. We also examined hepatic autophagy
in the liver tissue of db/db mice, which has been demonstrated
to suffer from severe depletion of b cells with age and to
develop severe diabetes in the KsJ genetic background. As
shown in Figure S2B, db/db mice also exhibit defective hepatic
Atg7 expression compared to lean controls (which is consistent
with our results in the ob/ob and HFD models), and reduction in
insulin level (occurring at 15 weeks) did not restore Atg7 expres-
sion in the liver tissue. These results indicate that hyperinsuline-
mia seen in obese mice is unlikely the primary cause for the
downregulation of Atg7.
Excess fatty acid accumulation in nonadipose tissues is a hall-
mark of metabolic disease, and recent studies suggested that an
abnormal increase in intracellular lipids might impair autophagic
clearance (Singh et al., 2009). Hence, we investigated whether
lipid exposure will lead to defective autophagy in liver. As shown
in Figure 2A, there was no alteration in Atg7 protein expression in
the liver tissue of mice after a short-term lipid infusion compared
to controls. Although there was amild increase in the Atg12-Atg5
conjugation, the LC3 conversion was decreased by exposure to
lipids, and no significant changes were evident in the expression
of Atg7, Atg5, and Lamp2 mRNAs (Figure 2B). Furthermore,
although the Atg7 protein level was dramatically decreased in
the liver of obese mice (Figure 1A), we did not observe a corre-
sponding decrease in Atg7 mRNA expression (Figure 2C), indi-
cating that alterative mechanisms may be involved in the
regulation of autophagy observed in obesity. Earlier studies
have also shown that Atg7, Atg5, and Beclin 1 could be cleaved
and degraded by the calcium-dependent protease calpain
2 (Kim et al., 2008; Yousefi et al., 2006). To explore the possibility
of calpain-mediated Atg7 depletion in obesity, we next examined
calpain 2 expression in the liver tissue of ob/ob mice. As shown
in Figure 2D, there was a marked (5-fold) increase in calpain
2 expression in liver of obese mice compared to lean controls.
Furthermore, acute inhibition of calpain by two different specific
calpain inhibitors (peptide and small molecule inhibitors) was
able to restore Atg7 expression (3- to 4-fold of obese levels) in
the obese liver tissue (Figure 2E). These results indicate that
obesity-induced increase in calpain 2 may be an important
mechanism leading to downregulation of Atg7 and then defec-
tive autophagy.
Suppression of Autophagy Results in Insulin Resistance
and ER Stress
To investigate the impact of autophagy on metabolic regulation,
particularly in the context of insulin responsiveness, we em-
ployed several approaches to interfere with autophagy and
examined insulin action in cultured cells. To determine the
regulation of insulin action during impaired autophagy, we
examined insulin receptor signaling in two cellular models
genetically deficient in Atg7 or Atg5 (Figure 3A). Consistent
with published reports, defective autophagy was also verified
in Atg7-deficient cells (Figures S3A and S3B). In both of these
cell types, there was a significant reduction in insulin-stimulated
Figure 1. Regulation of Autophagy in
Obesity
(A) Autophagy and ER stress indicators were
examined in liver tissue of obese (ob/ob) mice
and age- and sex-matched lean controls by
western blot analysis. Autophagy was evaluated
by the conversion of LC3-I to LC3-II, expression
of Beclin 1, Atg5, Atg7, and p62 proteins. ER
stress was examined by the phosphorylation of
IRE1 and PERK (the arrow indicates phosphory-
lated PERK).
(B) Representative electron micrographs (9,6903)
of livers of lean and obese mice. The pictures
shown on the right are high magnification
(57,8003) of the field marked with a red rectangle
on the left.
(C) Quantification of autophagolysosome-like
vacuoles per field in the EM images.
(D) Examination of autophagic markers in the liver
of obese mice and its age- and sex-matched lean
control after food withdrawal.
(E) Representative pictures of GFP-LC3 punctate
structures in livers of lean and obese mice ex-
pressing GFP-LC3, in the presence or absence
of chloroquine. The red arrows indicate the GFP-
LC3 punctate structure; the nuclei were stained
with DAPI shown in blue.
(F) Quantification of GFP-LC3 punctate structure
per cell.
Data are shown asmean ± SEM. Asterisk indicates
statistical significance determined by Student’s t
test (*p < 0.05). All mice are male and at the age
of 12–16 weeks.
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(IRb) and serine 473 phosphorylation of Akt, demonstrating
severe insulin resistance (Figure 3A). Of interest, as shown in
Figure S3A, deficiency of Atg7 not only resulted in decreased
level of Atg12-Atg5 conjugation, but also in defective expres-
sion of Atg5, suggesting that Atg7 is required for the mainte-
nance of Atg5 and plays a central regulatory role in autophagy
by controlling several downstream mediators. Considering the
potential limitations of the mouse embryonic fibroblasts used
in these experiments in reflecting physiological relevance,
Atg7 expression was also suppressed in murine hepatoma
cells, Hepa1–6, using an adenovirus-mediated shRNAi ap-
proach. In this system, suppression of Atg7 expression
(70%) resulted in decreased insulin-stimulated Akt Ser-473
(50%) and IR b subunit (60%) phosphorylation (Figure 3B).
These experiments indicated that genetic or molecular suppres-
sion of autophagy in multiple types of cells was detrimental for
insulin action.Cell Metabolism 11, 467–However, it is essential to determine
the physiological relevance of such a rela-
tionship between autophagy and insulin
action in an in vivo setting. To establish
this system, we suppressed Atg7 expres-
sion in the liver tissue of lean mice with
Atg7 or control shRNAs using an adeno-
virus-mediated approach in vivo. The
shRNA treatment resulted in 80% reduc-tion of Atg7 protein in these animals (Figures 4A and 4B). As
shown in Figure 4A, there was a marked reduction in the ability
of insulin to stimulate Akt (80%) and IR b subunit (70%) phos-
phorylation in liver of intact lean mice injected with adeno-Atg7
shRNAi, demonstrating severe insulin resistance upon suppres-
sion of Atg7. Hence, experiments in both cellular systems and
whole animals demonstrate the importance of the autophagy
process in insulin action.
We have previously demonstrated that the metabolic and
inflammatory stresses of obesity disrupt the homeostasis of
the ER, which, in turn, contributes to insulin resistance (Ozcan
et al., 2004). Recent studies also indicate that ER stress may be
linked to autophagy potentially through the degradation of
unfolded proteins and in the removal of superfluous ER
membranes (Bernales et al., 2007). Inhibition of autophagy
during ER stress increases apoptosis in many cellular settings,
suggesting an adaptive role for autophagy during the unfolded
protein response (Ogata et al., 2006). Of interest, we observed478, June 9, 2010 ª2010 Elsevier Inc. 469
Figure 2. Regulation of Atg7 in Liver of Lean
and Obese Mice
(A) Autophagy was examined in livers of wild-type
lean mice (10-week-old) treated with lipid infusion
or vehicle for 5 hr, using Atg7, conjugated Atg5,
and LC3 conversion as autophagymarkers. Quan-
tification is shown on the right.
(B)mRNAs coding for Atg7, Atg5, and Lamp2were
examined by quantitative RT-PCR in livers of lean
mice treated with vehicle (n = 3) or lipid infusion
(n = 5) for 5 hr. Results are presented as gene
expression levels in lipid infusion group normal-
ized to vehicle controls.
(C) mRNAs coding for Atg7 and Lamp2 were
examined by quantitative RT-PCR in livers of
lean mice or ob/ob mice (n = 3). Results are pre-
sented as gene expression levels in obese group
normalized to lean controls.
(D) Representative western blot of calpain
2 expression in the livers of ob/ob mice (n = 8)
and lean mice (n = 7) control. Quantification of
the blots is shown on the bottom.
(E) ob/obmice were injected with calpain inhibitor
III (10 mg/kg) and PD150606 (10 mg/kg), and liver
Atg7 expression was examined by western blot
assay. Quantification of the blots is shown on
bottom, with four mice in each treatment.
All data are shown as mean ± SEM. Asterisk indi-
cates statistical significance determined by
Student’s t test (*p < 0.05).
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also resulted in ER stress in the liver tissue of lean mice
(Figure 4B), as evident by the induction of eIF2a (eukaryotic
initiation factor 2 alpha) and PERK phosphorylation, and induc-
tion of Chop (C/EBP homologous protein), three well-known ER
stress indicators. This pattern is reminiscent of the observa-
tions made in obese liver and suggests that autophagy may
be integrated to ER homeostasis in impacting insulin action.
Consistent with the biochemical alterations, insulin resistance
was evident in lean mice in insulin tolerance tests (ITT) upon
Atg7 suppression (Figure 4C). Serum insulin level was signifi-
cantly increased; however, glucose levels remained slightly470 Cell Metabolism 11, 467–478, June 9, 2010 ª2010 Elsevier Inc.,
,lower in mice after the suppression of
Atg7 (Figures 4D and S4E). This
decreased basal glucose level is likely
caused by impairment of lysosome and
autophagy-mediated glycogen break-
down (Kotoulas et al., 2004), which is
supported by the evidence of increased
hepatic glycogen content in lean mice
after suppression of liver Atg7 (Figures
S4F and S4G). In addition, expression
of mRNAs coding for glycogen phos-
phorylase and a-glucosidase, two key
glycogen breakdown enzymes, was also
significantly decreased in lean mice
following Atg7 suppression (Figure S4H).
In these mice, despite indications for a
mild hepatomegaly (Figure S4A), we didnot observe a significant change in liver lipid accumulation, and
no alterations were evident in body weight, serum triglyceride
or free fatty acid levels (Figures S4B–S4D). Taken together
these data link autophagy to insulin action and ER stress in the
liver and demonstrate the systemic metabolic impact of hepatic
autophagy deficiency in vivo.
Restoration ofHepatic Autophagy inObeseMiceResults
in Enhanced Systemic Glucose Homeostasis, Insulin
Action, and Ameliorated ER Stress
Though disrupting the autophagic response in cells and
liver tissue appeared causal to insulin resistance, these
Figure 3. Suppression of Autophagy
Results in Impaired Insulin Signaling
(A) Wild-type (WT), Atg7/, or Atg5/ MEF cells
were stimulated with 50 nM insulin. Insulin
receptor signaling was detected by western blot
analysis of phosphorylation of IR tyrosine 1162/
1163 (p-IR) and Akt serine 473 (p-Akt), with quan-
tification shown on the right. Results represent fold
induction by insulin compared to basal levels in
each group.
(B) Hepa1–6 cells were transduced with adeno-
virus-mediated control shRNAi to LacZ (Ad-LacZ)
or shRNAi to Atg7 (Ad-shAtg7) at a titer of 2 3
109 vp/ml per well in 12-well plate. At 48 hr later,
cells were stimulated with 10 nM insulin (In) for
3min, and the insulin receptor signalingwas exam-
ined by western blot analysis. Quantification is
shown on the right.
Results represent fold induction by insulin
compared to basal levels in each group. Data are
shown as mean ± SEM. Asterisk indicates statis-
tical significance determined by Student’s-t test
(*p < 0.05).
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agy to abnormal insulin action seen in obesity. We reasoned
that, because autophagy response is already defective in ob-
esity, a definitive link could be established if autophagy is
reconstituted in the obese animals, and this intervention results
in enhanced insulin action. Among the many autophagy-related
(Atg) genes that regulate autophagy, Atg7, which encodes
a ubiquitin-activating enzyme (E1)-like enzyme, is central for
autophagosome formation (Tanida et al., 1999) responsible
for both Atg12-Atg5 conjugation and LC3 conversion. Because
Atg7 is dramatically downregulated in the liver of ob/ob mice
(>90%, Figure 1A), we reasoned that reconstitution of Atg7
expression would likely be an effective way to reestablish
autophagy, at least in part, in the livers of obese mice. To
test the possibility that the defects in hepatic autophagy and
particularly in Atg7 seen in obesity might be causal for insulin
resistance in vivo, we expressed Atg7 using an adenoviral
system in the liver tissue of ob/ob animals to examine its
metabolic impact. After adenoviral delivery, we verified that
expression of Atg7 was significantly elevated (5-fold) in the
liver tissue of obese mice, compared to vector controls
(Figure 5A), bringing its levels closer to what has been detected
in lean controls. This modest increase in the expression of
Atg7 in obese mice led to increased autophagy, as evident
by increased conjugated Atg5 expression, increased Beclin 1
expression, a higher LC3 conversion, and a decrease in p62
expression level in liver tissue compared to control mice, indi-
cating that the strategy employed in this setting was, at least
in part, successful in reconstituting Atg7 and autophagic
activity in vivo. We also examined whether our adenoviralCell Metabolism 11, 467–strategy primarily targeted liver tissue
by measuring both GFP and exogenous
Atg7 expression in other insulin-sensitive
tissues/organs of the ob/ob mice. As
shown in Figures S5A and S5B, both
GFP and Atg7 expression was readilydetectable in the liver tissue of ob/ob mice injected with
Ad-GFP or Ad-Atg7 but was not detectable in muscle and
adipose tissue.
We next asked whether expression of Atg7 in the ob/ob liver
tissue, which is severely defective in both Atg7 expression and
insulin action, could rescue the defects in insulin receptor
signaling. Upon insulin stimulation, Atg7-expressing obese
animals exhibited a markedly enhanced tyrosine 1162/1163
phosphorylation of insulin receptor b subunit (IRb) and serine
473 phosphorylation of Akt in liver tissue (Figure 5B) compared
to controls. Moreover, restoration of Atg7 expression resulted
in significant reduction in obesity-induced ER stress in the liver
of ob/obmice, as evidenced by decreased levels of phosphory-
lated PERK, eIF2a, and HERP (homocysteine-inducible ER
stress protein) proteins, as well as ER stress-inducible mRNAs
coding for Grp78 (glucose regulate protein 78), Chop, PDI
(protein disulfide isomerase), Gadd34 (growth arrest and DNA
damage-inducible gene 34), and ERdj4 (endoplasmic retic-
ulum-localized DnaJ homolog) compared to control mice
(Figures 5C and 5D). Examination of total liver tissue and liver
sections demonstrated that Atg7 complementation resulted in
reduced hepatic fatty acid infiltration (Figures 6A and 6B), liver
triglyceride content (Figure 6C), and serum insulin level
(Figure 6D). There was a modest increase in serum triglyceride,
but not free fatty acid levels, in mice expressing exogenous
Atg7 (Figures S5C and S5D). It is possible that enhanced autoph-
agy reduced lipid accumulation through an increase in lipid
metabolism, as proposed by Singh et al. (2009). Of interest, in
this system, a significant decrease was also apparent in the
expression of FAS and SCD1 transcripts (Figure S5E), which478, June 9, 2010 ª2010 Elsevier Inc. 471
Figure 4. Defective Autophagy Results in
Insulin Resistance
(A) Hepatic insulin action in lean mice following
in vivo Atg7 knockdown with shRNAi. Lean mice
(male, 14-week-old, C57BL/6J) were injected
with Ad-LacZ or Ad-shAtg7. Insulin signaling was
examined in intact mice following hepatic insulin
administration. Quantification of the data is shown
on right, with the averaged results of four mice in
each treatment group. Results represent fold
induction by insulin compared to basal levels in
each group. Data are shown as mean ± SEM.
Asterisk indicates statistical significance deter-
mined by Student’s t test (*p < 0.05).
(B) Examination of ER stress in livers of lean mice
following Atg7 knockdown in vivo. Chop, PERK,
and eIF2a phosphorylation were detected by
western blot analysis, and Atg7 and tubulin
proteins are shown as controls. Quantification of
the data is shown on right. Results represent fold
change in each molecule by Ad-shAtg7 to Ad-
LacZ.
(C) Insulin tolerance test was performed in lean
mice (n = 8) following Atg7 knockdown (n = 8).
Results represent blood glucose concentrations
relative to the starting value. All data are presented
as mean ± SEM, with statistical analysis per-
formed by repeated-measures two-way ANOVA
(*p < 0.05).
(D) Serum insulin level was measured in lean mice
after 6 hr fasting following Atg7 knockdown.
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was also seen for SREBP1 and ACC1, but these changes did
not reach statistical significance (p = 0.059 and 0.067, respec-
tively). Hence, it is possible that, in this setting, a reduction in lipid
synthesis also contributed to improved hepatosteatosis. In
agreement with enhanced hepatic insulin action, we also
observed that expression of genes involved in gluconeogenesis
was also attenuated by overexpression of Atg7 in liver of ob/ob
mice (Figure S5E).
We next examined insulin action and glucose metabolism in
these animals. Glucose and insulin tolerance tests (GTT and
ITT) demonstrated significantly improved glucose tolerance
and insulin sensitivity in ob/ob mice expressing Atg7 compared
with mice injected with the control virus (Figures 6E and 6F).
We also explored the effect of liver Atg7 complementation in
a dietary model of obesity. Adenoviral delivery of Atg7
improved glucose tolerance in the HFD model of obesity,472 Cell Metabolism 11, 467–478, June 9, 2010 ª2010 Elsevier Inc.without any changes in body weight
(Figures S1C and S1D). These results
demonstrate enhanced systemic insulin
sensitivity upon reconstitution of Atg7
expression in livers of mice with genetic
or dietary obesity, and that reconstitution
of Atg7 expression in the liver tissue of
obese mice resulted in improved liver
and systemic insulin sensitivity and
glucose homeostasis.
To analyze the action of the autophagy
on systemic glucose fluxes and insulinaction in greater detail, we performed hyperinsulinemic-euglyce-
mic clamp studies in ob/ob mice upon reconstitution of hepatic
Atg7. As shown in Figures 6G and 6H, restoration of Atg7 expres-
sion resulted in a significant reduction in hepatic glucose
production (HGP) both at baseline and during the clamp studies.
Glucose infusion rates (GIRs) to maintain euglycemia were also
higher in the ob/ob mice expressing Atg7 compared to controls
(Figure 6I). Consistent with this result, glucose uptake in muscle
tissue was also increased in Atg7-expressing ob/ob mice
compared with controls (Figure 6J). These data demonstrate
that the restoration of Atg7 in the liver tissue of ob/ob mice
improves whole-body insulin sensitivity through the suppression
of hepatic glucose production and enhancement of insulin-stim-
ulated glucose disposal in the periphery.
Though our in vitro and in vivo experiments strongly link au-
tophagy to insulin action, it is still possible that, particularly in
light of the data produced by the expression of Atg7 in liver,
Figure 5. Restoration of Autophagy and Improvement of Insulin Action by Reconstitution of Atg7 in Obese Mice
(A) Autophagy in ob/obmice following adenoviral expression of Atg7 or control vector (GFP). Atg7, Atg12-Atg5 conjugation, Beclin 1 expression, LC3 conversion,
and p62 levels were examined as autophagy markers.
(B) Insulin-stimulated IR tyrosine 1162/1163 (p-IR) and Akt serine 473 (p-Akt) phosphorylation in the livers of ob/obmice expressing Atg7 or control vector (GFP).
Atg7 and tubulin are used as controls. Quantification of the data is shown on the right. Results represent fold induction by insulin compared to basal levels in each
group.
(C) Phosphorylation of PERK and eIF2a and expression of HERP proteins in the livers of ob/ob mice expressing Atg7 or control (GFP) proteins by adenoviral
delivery. Actin is shown as a control, and quantification of the data is shown on the right. Results represent fold change in each molecule by Ad-Atg7 to Ad-GFP.
(D)mRNAs coding for Grp78, Chop, PDI, Gadd34, and ERdi4 were examined by quantitative RT-PCR in livers of ob/obmice reconstitutedwith Atg7. n = 8. Results
are presented as gene expression levels in Atg7 group normalized to controls (GFP).
All data are shown as mean ± SEM. Asterisk indicates statistical significance determined by Student’s t test (*p < 0.05).
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anisms that are independent of the autophagy process. To
address this question in a relevant in vivo setting, we set out to
introduce a block in autophagy using a dominant-negative
form of Atg5 (DN-Atg5) (Hamacher-Brady et al., 2007) in ob/ob
mice in which Atg7 expression is also reconstituted in the liver.
The action of the DN-Atg5 was first confirmed in a hepatocyte
cell line in which inhibition of autophagy was verified by forma-
tion of GFP-LC3 punctate structures (Figure S6). As shown in
Figures 7A and 7B, control ob/ob mice have impaired glucose
tolerance and insulin tolerance, and restoration of Atg7 signifi-
cantly improved the systemic glucose disposal and insulin sensi-
tivity. Expression of DN-Atg5 did not have any effect on these
parameters in obese mice. This is an expected result because
autophagy is already severely defective in the ob/ob liver.
However, coexpression of DN-Atg5 completely abolished the
positive effects of Atg7 on systemic insulin sensitivity in the ob/
ob animals. In the presence of DN-Atg5, Atg7 expression could
not rescue obesity-induced defects in insulin action. Further-
more, we examined insulin signaling in the liver tissue of theseCobese mice. As shown in Figures 7C and 7D, restoration of
Atg7 improved insulin receptor signaling in the liver of ob/ob
mice, and this effect was completely negated by the coexpres-
sion of DN-Atg5. These experiments showed that the effects of
Atg7 on enhancing insulin signaling and insulin sensitivity
involve, at least in part, its regulation of autophagy and were
blocked by interfering with this response through a downstream
effector molecule in vivo.
DISCUSSION
In this study, we demonstrate that defective autophagy is causal
to impaired hepatic insulin sensitivity and glucose homeostasis
in obesity. Combinedwith the potential reported role in islet func-
tion and survival (Ebato et al., 2008; Jung et al., 2008), the data
presented here indicate that autophagymay be a relevant mech-
anism for the two major pathological arms of type 2 diabetes:
impaired insulin secretion and insulin sensitivity. Our findings
raise several interesting possibilities. In obesity, significant au-
tophagy defects are observed in the liver tissue (Figures 1ell Metabolism 11, 467–478, June 9, 2010 ª2010 Elsevier Inc. 473
Figure 6. Metabolic Effects of Liver Atg7 Restoration in Obese Mice
(A) Gross anatomical views of representative livers of ob/ob mice expressing Atg7 (Ad-Atg7) or control vector (Ad-GFP).
(B) Representative images of H&E staining (403) in ob/ob mice liver expressing Atg7 or control vector.
(C and D) Triglyceride (Tg) content of the liver (C) and serum insulin level (D) weremeasured in ob/obmice expressing Atg7 (n = 8) or control vector (n = 8). Data are
shown as mean ± SEM. Asterisk indicates statistical significance determined by Student’s t test (*p < 0.05).
(E) Glucose tolerance test (GTT) performed in ob/ob mice following injection of Adeno-GFP (Ad-GFP, n = 8) or Adeno-Atg7 (Ad-Atg7, n = 8).
(F) Insulin tolerance test in ob/ob mice following injection of Ad-GFP or Ad-Atg7. All data are presented as mean ± SEM, with statistical analysis performed by
repeated-measures two-way ANOVA (*p < 0.05). Hyperinsulinaemic-euglycaemic clamp studies were performed in ob/obmice transducedwith Ad-GFP (n = 7) or
Ad-Atg7 (n = 6).
(G–J) Basal and clamp hepatic glucose production (HGP) (G andH), glucose infusion rate (GIR) (I), and glucose uptake in gastrocnemiusmuscle (J) were analyzed.
Data are shown as the mean ± SEM (*p < 0.05).
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stress. It has been shown that nutrient and energy surplus and
inflammatory milieu associated with obesity compromise the
function of the ER in major metabolic cell types and lead to
insulin resistance (Hotamisligil, 2010). Here, we show that474 Cell Metabolism 11, 467–478, June 9, 2010 ª2010 Elsevier Inc.impaired autophagy could also contribute to ER stress in lean
mice and that restoration of autophagy dampens obesity-
induced liver ER stress in vivo. Hence, it would be plausible
that one function of autophagy is to facilitate elimination or repair
of damaged/distressed organelles and/or assist their adaptive
Figure 7. Autophagy-Dependent Regulation of Systemic Insulin Action by Atg7 in Obese Mice
(A and B) Glucose (A) and insulin (B) tolerance tests in ob/ob mice expressing dominant-negative Atg5 (DN-Atg5+GFP), Atg7 (Atg7+GFP), or a combination
(Atg7+Dn-Atg5). GFP virus alone is the control. Results represent blood glucose concentrations relative to the starting value. All data are presented as
mean ± SEM, with statistical analysis performed by repeated-measures ANOVA (*p < 0.05). Each group contained eight mice at 9 weeks of age.
(C) Insulin-stimulated phosphorylation of IR tyrosine 1162/1163 (p-IR) and Akt serine 473 (p-Akt) in the livers of ob/ob mice expressing GFP, Atg7+GFP,
DN-Atg5+GFP, or Atg7+DN-Atg5. Quantification of each molecule shown is on the right. Results represent fold induction by insulin compared to basal levels
in each group of mice. Data are shown as mean ± SEM. Asterisk indicates statistical significance determined by Student’s t test (*p < 0.05).
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can induce autophagy to participate in the degradation of
unfolded proteins and in the removal of superfluous ER
membranes (Bernales et al., 2007). Failure to achieve this may
compromise ER function in the face of continuous energy and
nutrient stress; engage inhibitory signals for autophagic and
ER stress responses; further organelle dysfunction; and create
a vicious cycle resulting in metabolic deterioration, insulin resis-
tance, and type 2 diabetes. Future studies should address
whether other mechanisms are also involved in integrating au-
tophagy or critical molecules in autophagy to insulin action or
other aspects of metabolism, for example, the reported autoph-
agy-mediated clearance of misfolded insulin receptor induced
by ER stress (Zhou et al., 2009). There are many parallels
between age-related impairment in metabolism and pathologies
associated with obesity, both of which benefit from caloric
restriction. Intriguingly, caloric restriction is also an effective
strategy to enhance autophagy (Wohlgemuth et al., 2007).
Hence, metabolic regulation by autophagy may have implica-
tions beyond obesity-induced insulin resistance and type 2 dia-
betes.
Although we observed severe deficiency of autophagy in the
liver of obese mice, the cause of this defect and, particularly,
the mechanisms leading to downregulation of Atg7 could beCdiverse. Because obesity is characterized with enhanced lipid
accumulation in the liver, it is plausible that chronic lipid over-
loading or sustained lipogenesis might be one of the triggers,
although we did not observe significant alteration of autophagic
markers in the liver tissue of lean mice treated with a short-term
lipid infusion (Figures 2A and 2B). Recently, Singh et al. (2009)
demonstrated that autophagy plays an important role in lipid
metabolism and inhibition of autophagy increases hepatic lipid
storage during starvation. We did not observe hepatic steatosis
or changes in serum triglyceride and fatty acid levels in leanmice
following shRNA-mediated suppression of Atg7 (Figures S4A–
S4D). Although we did not investigate lipid metabolism in our
model under prolonged starvation conditions, it is possible that
the role of autophagy in lipid metabolism might be much more
complicated than expected and may depend on the develop-
mental stage of the interventions or the age of the experimental
animals. It is also likely that severe defects induced by genetic
deletion of major autophagy components disrupt major homeo-
static pathways, and therefore, the impact of such experimental
manipulations could vary depending on the timing, severity of the
effects, and the metabolic demands of the target tissues. In fact,
it is reported that starvation-induced lipid droplet formation is
suppressed in the liver of Atg7-deficient mice at a younger age
(Shibata et al., 2009). Furthermore, ER stress could also act toell Metabolism 11, 467–478, June 9, 2010 ª2010 Elsevier Inc. 475
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et al., 2009; Su et al., 2009), both of which could alter hepatic lipid
accumulation. Thus, ER stress induced by impaired hepatic
autophagy as observed in our model may further accelerate lipid
accumulation in the liver under defined conditions such as
starvation.
Moreover, it has been reported that insulin can suppress
autophagy through the mTOR or Akt/FOXO3 pathways
(Mammucari et al., 2007; Xie and Klionsky, 2007). Most recently,
it has been proposed that insulin may also contribute to downre-
gulation of some Atg genes, although this direct link was exam-
ined in lean mice (Liu et al., 2009). However, it is likely that
impaired autophagy is also an upstream regulator of insulin
resistance, as demonstrated here. Furthermore, reduction of
insulin level in obese mice (ob/ob and db/dbmousemodels) fails
to recover Atg7 deficiency (Figure S2), but suppression of Atg7
directly results in systemic and hepatic insulin resistance in
lean mice (Figure 4). It is nevertheless possible that, during the
early stages of obesity, hyperinsulinemia may contribute to the
dampening of the initiation of autophagic machinery, which
would further the organelle dysfunction, disrupt metabolic
homeostasis, and promote the emergence of disease. Lastly,
as an E1-like enzyme, Atg7 plays a major role for autophago-
some formation and LC3 activation (Tanida et al., 1999). We
showed that Atg7 is severely downregulated at the protein level
in the liver of obese mice (Figures 1A, S1A, and S1B). However,
there was no decrease in the levels of Atg7 mRNA in the liver
tissue of obese mice, a proposed mechanism of insulin action
on Atg7 expression (Liu et al., 2009), compared to lean controls
(Figure 2C). Thus, a distinct mechanism(s) is likely to account for
the downregulation of Atg7. Of interest, we identified a dramatic
increase in calpain 2 protein expression in liver of ob/ob mice
compared to lean controls (Figure 2D), and inhibition of calpain
activity in vivo by two independent calpain inhibitors resulted
in enhanced Atg7 protein expression level (Figure 2E). It has
also been reported that calpain 2 may play an important role
in Beclin 1 and Atg7 depletion in anoxic rat hepatocytes (Kim
et al., 2008). Hence, we suggest that the calpain-mediated
depletion of Atg7 may be a critical contributing mechanism to
obesity-related defects in Atg7 protein levels and related auto-
phagic responses.
Regardless, defective autophagy and insulin resistance are
highly integrated in mice and impose a major effect on systemic
metabolism. In addition to insulin sensitivity, suppression of au-
tophagy also results in alterations of glycogen accumulation in
the liver of lean mice (Figures S4F–S4H), which is increased in
obesity. Because autophagy is involved in gluconeogenesis
and lysosome plays an important role in glycogen breakdown
(Kotoulas et al., 2004), our results are consistent with a modest
reduction in blood glucose despite insulin resistance upon
suppression of Atg7 in vivo (Figure S4E). In fact, suppression
of autophagy also results in a significant decrease in lysosomal
acid a-glycosidase, which is produced in ER and routed through
Golgi complex to the lysosomes. Given the enhanced ER stress
in liver of lean mice upon suppression of Atg7, it is plausible that
the defective glycogen breakdown in this model may be a direct
consequence of disturbed ER homeostasis. Though we have
demonstrated that the impact of Atg7 on insulin sensitivity is,
at least in significant part, dependent on autophagy, the possi-476 Cell Metabolism 11, 467–478, June 9, 2010 ª2010 Elsevier Inc.bility remains that some part of Atg7 action on liver metabolism
may still involve yet unknown and autophagy-independent
mechanisms. Future studies are warranted to explore such
possibilities to fully understand the metabolic impact of this
adaptive response and how insulin action is influenced by
different autophagymediators. Taken together, our observations
underscore the importance of the delicate and coordinated regu-
lation of autophagic responses during metabolic homeostasis.
It remains an intriguing possibility that small-molecule modula-
tors of autophagy or central molecules controlling this process
could facilitate the exploitation of this adaptive pathway for ther-
apeutic interventions against obesity and type 2 diabetes.
EXPERIMENTAL PROCEDURES
Cell Culture and Reagents
Hepa1–6 (murine hepatoma cell line), HEK293A, and MEF cells were cultured
in DMEM (Invitrogen) with 10% fetal bovine serum (Thermo Scientific). Twenty
mME64d (Merck) was used to inhibit lysosomal proteases when indicated. For
insulin signaling, Hepa1–6 cells were stimulated with 10 nM insulin for 3 min;
MEF cells were stimulated with 50 nM insulin for 10 min.
Adenovirus Transduction
The shRNAi for Atg7 was designed against mouse Atg7 (sense: 50-ATGAGA
TCTGGGAAGCCAT-30) using pSilencer design tool (Ambion). The hairpin
template oligonucleotides were synthesized by Integrated DNA Technologies,
followed by annealing and inserting into adenovirus shuttle vector by using
pSilencer system (Ambion) according to manufacturer’s protocol. The adeno-
virus carrying Atg7 is a generous gift from Dr. Kim (University of Florida). The
adenovirus carrying DN-Atg5 is generated by using Gateway system (Invitro-
gen). Adenoviruses were amplified in HEK293A cells and purified by CsCl
gradient centrifugation. The viruses were titered and transduced into the cells
as described (Cao et al., 2008).
Western Blot Analysis
Proteins were extracted from tissues and subjected to SDS-polyacrylamide
gel electrophoresis, as previously described (Furuhashi et al., 2007).
Membranes were incubated with anti-LC3 (Novus), anti-Beclin 1 (Cell
Signaling), anti-Atg7 (Abgent), anti-Atg5 (Abgent), anti-conjugated Atg12-
Atg5 (Novus), anti-p62 (Abgent), anti-Actin (Santa Cruz), anti-tubulin (Santa
Cruz), anti-p-Akt (Santa Cruz), anti-p-IR (Calbiochem), anti-Akt (Santa Cruz),
anti-IR (Santa Cruz), anti-p-PERK (Cell Signaling), anti-PERK (developed in
house), anti-HERP (kind gift from Dr. Yasuhiko Hirabayashi of Tohoku Univer-
sity, Japan), anti-p-IRE1 (Novus), anti-p-eIF2a (Invitrogen), anti-Chop (Santa
Cruz), or anti-calpain 2 (Cell Signaling) antibodies overnight at 4C. The
membranes were incubated with the secondary antibody conjugated with
horseradish peroxidase (Amersham Biosciences) and were visualized using
the enhanced chemiluminescence system (Roche Diagnostics). The densito-
metric analyses of western blot images were done by using Quantity One Soft-
ware (Bio-Rad).
Quantitative Real-Time RT-PCR
Total RNA was isolated using Trizol reagent (Invitrogen) and converted into
cDNA using a cDNA synthesis kit (Applied Biosystems). Quantitative real-
time PCR analysis was performed using SYBR Green in 7300 Real Time
PCR System (Applied Biosystems). The primers were synthesized and
purchased from Integrated DNA Technologies, and the sequences are pre-
sented in the Supplemental Experimental Procedures.
Electron Microscopy
Mice were anesthetized with tribromoethanol followed by sequential portal
vein perfusion of 10 ml NaCl (0.9%), dilute fixative, and concentrated fixative.
For EM analysis, tissues were treated for 1 hr with 1% osmium tetroxide and
1.5% potassium ferrocyanide and then for 30 min with 0.5% uranyl acetate
in 50 mM maleate buffer (pH 5.15). After dehydration in ethanol, tissues
were treated for 1 hr in propylenoxide and embedded in Epon/Araldite resin.
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1200EX transmission electron microscope. For quantification of autophagoly-
sosome-like vacuoles, the numbers of autophagolysosomal-like vacuoles
were counted in each field and normalized by the surface area.
Mouse Models, Calpain Inhibition, and Administration
of the Adenoviruses
Male ob/ob mice at 6 weeks of age were purchased from Jackson Labs and
kept on a 12 hr light/dark cycle and fed with regular diet for 4–8 weeks. Mice
used in the diet-induced obesity model were male C57BL/6J purchased
from Jackson Labs, which were placed on HFD (35.5% fat, 20% protein,
32.7% carbohydrates, Research Diets) immediately after weaning. Adenovirus
carrying Atg7, GFP, DN-Atg5, LacZ-shRNA, or Atg7-shRNA was delivered into
the ob/ob (or HFD) mice or lean mice intravenously at a titer of 3 3 1011 vp/
mice. In the case of coexpression experiments, two types of viruses were first
mixed with equal titers amount, and each virus was delivered to mice at a titer
of 1.53 1011 vp/mice. After 7–10 days, glucose and insulin tolerance tests and
hepatic portal vein insulin injections were performed as described below. For
calpain inhibition experiments, male ob/obmice (10 weeks) were injected with
vehicle (DMSO), calpain inhibitor III (Calbiochem), or PD150606 (Calbiochem)
at 10 mg/kg through intraperitoneal injection. At 6 hr after injection, mice were
sacrificed and tissues were removed and frozen in liquid nitrogen and kept
at 80C until processing.
In Vivo Analysis of GFP-LC3 Punctuated Structures
GFP-LC3-expressing adenovirus was delivered into lean or ob/ob mice intra-
venously at a titer of 2 3 1011 vp/mice. After 7 days, mice received either
vehicle or chloroquine (10 mg/kg/day) (Yuan et al., 2009) by intraperitoneal
injection for 2 days followed by an overnight fast. Livers were then harvested
and processed for frozen section. Thawed tissue slides were fixed with 4%
paraformaldehyde in PBS for 10 min at room temperature and sealed with
mounting solution with DAPI (Vector Labs). Punctuated GFP-LC3 and nuclei
in each view were quantified by using particle analysis tool of ImageJ software
(NIH); GFP-LC3 punctuates per cell was calculated based on the number of
nuclei.
Plasma and Liver Triglyceride Measurements
Plasma insulin was measured in mice after a 6 hr food withdrawal with
a commercially available ultra-sensitive ELISA assay (Crystal Chemicals). Liver
triglycerides were determinedwith colorimetric assay systems (Sigma-Aldrich)
adapted for microtiter plate format (Furuhashi et al., 2007).
Glucose and Insulin Tolerance Tests and Insulin Infusions
Glucose tolerance tests were performed by intraperitoneal glucose injection
(1 g kg1) after an overnight fast, and insulin tolerance tests were performed
by intraperitoneal insulin injection (1.0 IU kg1) after a 6 hr fast (Furuhashi
et al., 2007). Following 6 hr of food withdrawal, ob/obmice were anaesthetized
with an intraperitoneal injection of tribromoethanol (250 mg kg1), and insulin
(1 IU kg1) or phosphate buffered saline (PBS) in 200 ml volume was infused
into the portal vein. Three minutes after infusion, tissues were removed and
frozen in liquid nitrogen and kept at 80C until processing.
Hyperinsulinemic-Euglycemic Clamp Studies
Five days after delivery of control or Atg7 expression vectors, surgery was
performed to catheterize the jugular vein. Clamp experiments were performed
at day 4 of postsurgery as previously described (Furuhashi et al., 2007). To
determine [3H]-glucose and 2-[14C]-DG concentrations, plasma samples
were deproteinized with ZnSO4 and Ba(OH)2, dried, resuspended in water,
and counted in scintillation fluid for detection of 3H and 14C. Tissue 2-[14C]-
DG-6-phosphate (2-DG-6-P) content was determined in homogenized
samples that were subjected to an ion-exchange column to separate 2-DG-
6-P from 2-[14C]-DG.
Lipid Infusion Experiments
Mice were anaesthetized, and the right jugular vein was catheterized. After
a 3 day recovery, mice were fasted for overnight followed by an infusion of lipid
(5 ml/kg/hr; Intralipid; Baxter Healthcare Corporation) or saline for 5 hr
(Nakamura et al., 2010).CSUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at doi:10.1016/j.cmet.
2010.04.005.
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